Hyperactivity of this pathway is related to addiction and the positive symptoms of schizophrenia [13], and the antagonism of D2R in the mesolimbic pathway has been used to treat positive psychotic symptoms [14]. This evidence concerns the gene DRD2 and schizophrenia.